Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,239,824 papers from all fields of science
Search
Sign In
Create Free Account
Sorafenib:MCnc:Pt:Ser/Plas:Qn
Known as:
Sorafenib:Concentración de masa:Punto temporal:Suero o Plasma:Qn
, Sorafénib:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique
, Sorafenib:KütlKons:Zml?:Ser/Plaz:Kant
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Plas
Serum
Unit of Mass Concentration
sorafenib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
Yu-Min Feng
,
C. Feng
,
Chin-Li Lu
,
Ming‐Yang Lee
,
Chi-yi Chen
,
Solomon Chih Cheng Chen
Japanese journal of clinical oncology
2015
Corpus ID: 15418722
Objective Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of…
Expand
Highly Cited
2014
Highly Cited
2014
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
S. Dixon
,
Darpan N. Patel
,
+8 authors
B. Stockwell
eLife
2014
Corpus ID: 1831118
Exchange of extracellular cystine for intracellular glutamate by the antiporter system xc− is implicated in numerous pathologies…
Expand
Review
2013
Review
2013
Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain
D. Castellano
,
M. Duh
,
+4 authors
J. Bellmunt
Expert opinion on drug safety
2013
Corpus ID: 40009393
Objective: To examine real-world safety and treatment patterns of angiogenesis inhibitors for advanced renal cell carcinoma (aRCC…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE